By Tim Wright, Editor, Contract Pharma03.03.21
Oral solids continue to be the most commonly used delivery vehicle to get drugs to patients for three main reasons: they are cost-effective, relatively easy to manufacture, and most importantly, are patient-friendly.
By the numbers, oral solid dosage (OSD) products remain the largest segment of the pharmaceutical market. The global OSD pharmaceutical formulation market is forecasted to grow from $493 billion in 2017 to $926 billion by the end of 2027, according to Future Market Insights. This represents a compound annual growth rate (CAGR) of 6.5% over the 10-year forecast period.
In terms of New Molecular Entities (NMEs), from 2015-19, between 70% and 80% of NMEs approved by the FDA were small molecules. In 2019, 68% of the small molecules approved were delivered through oral dosages.
“The current state of oral solid dose manufacturing is both mature—in that conventional tablet formulations and capacity exist—and immature—in that new formulation capabilities need to be developed and improved for more complex problem statements like bioavailability enhancing technologies and patient centric dosage forms like pediatric c
By the numbers, oral solid dosage (OSD) products remain the largest segment of the pharmaceutical market. The global OSD pharmaceutical formulation market is forecasted to grow from $493 billion in 2017 to $926 billion by the end of 2027, according to Future Market Insights. This represents a compound annual growth rate (CAGR) of 6.5% over the 10-year forecast period.
In terms of New Molecular Entities (NMEs), from 2015-19, between 70% and 80% of NMEs approved by the FDA were small molecules. In 2019, 68% of the small molecules approved were delivered through oral dosages.
“The current state of oral solid dose manufacturing is both mature—in that conventional tablet formulations and capacity exist—and immature—in that new formulation capabilities need to be developed and improved for more complex problem statements like bioavailability enhancing technologies and patient centric dosage forms like pediatric c
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
